Clinical Trial Update: Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer

View source ↗

Summary

This update summarizes quality-of-life findings from a completed trial evaluating Arimidex (anastrozole) in postmenopausal women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED